Psychopharmacology in patients with hepatic and gastrointestinal disease.
Psychotropic drugs often need to be prescribed to patients who also have pre-existing gastrointestinal (GI) and/or hepatic disease. This paper addresses the effect of GI and hepatic disease on the pharmacokinetics of psychotropic drugs, the effect of psychotropic drugs on pre-existing GI and hepatic diseases, the adverse GI and hepatic effects of psychotropic medications, the effects of GI medications on mental status, and the potential drug interactions between commonly prescribed GI medications and psychotropic drugs. Drug selection and dosage modification based on these considerations should allow safe and effective psychotropic treatment for patients with pre-existing GI and/or hepatic disease.
Leipzig
R M
RM
Hillside Hospital/LIJMC, Glen Oaks, NY 11004.
D005767:Gastrointestinal Diseases / Q000097:blood*; D006801:Humans; D008107:Liver Diseases / Q000097:blood*; D001523:Mental Disorders / Q000097:blood* / Q000188:drug therapy; D008657:Metabolic Clearance Rate / Q000502:physiology; D011619:Psychotropic Drugs / Q000493:pharmacokinetics* / Q000627:therapeutic use
D011619:Psychotropic Drugs